Netcare Limited (NTCP)
Johannesburg Exchange · South Africa · prices in ZAC · close of 22 Oct 2026
Key indicators
| Last close | ZAC 9,625.00 |
|---|---|
| 52-week range | 9,002.00 – 12,499.00 |
| Return, 1 month / 3 months | −5.6% / +2.9% |
| Return, 1 year / 3 years | +1.3% / +17.4% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 42 |
| Volatility (1 year) | 40.2% |
| Worst drawdown (1 year) | -24.0% |
| Average daily value traded | 20.38M ZAC |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Netcare Limited is a private healthcare provider based in South Africa. It operates a network of private hospitals offering surgical, medical and emergency care, along with primary care and dental clinics serving communities across the country. Its customers include individual patients, medical schemes and employers who pay for treatment, and the company also runs emergency medical response services. Netcare focuses on hospital care, specialist treatment and related health services delivered through its facilities and clinical teams.
Netcare Limited trades under the code NTCP on the Johannesburg Exchange in South Africa, with its price quoted in South African cents (ZAC). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Netcare Limited (NTCP) trades on the Johannesburg Exchange in South Africa. It last closed at ZAC 9,625.00 on 22 October 2026.
Its price-based Market X-Ray is 50 out of 100 (a weak price profile), ranking 129 of 238 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 1.3% and over the last three months it rose 2.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Johannesburg Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 61 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 1.0% | ||
| From 52-week high | -23.0% | ||
| Momentum | 60 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 2.9% | ||
| 6-month return | 1.9% | ||
| 12-month return, skipping the last month | 7.4% | ||
| Stability (higher is calmer) | 48 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 40.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.0% | ||
| Liquidity | 16 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 20.38M ZAC | ||
| Zero-volume days | 41.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −0.3% |
|---|---|
| 1 month | −5.6% |
| 3 months | +2.9% |
| 6 months | +1.9% |
| 1 year | +1.3% |
| 3 years | +17.4% |
| 5 years | +50.3% |
Signals
| 50-day / 200-day average | 9,940.12 / 9,529.55 |
|---|---|
| Golden / death cross (60 days) | Golden, 33 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 173.92 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 May 2023 | ZAC 426.3441 |
| 9 Nov 2022 | ZAC 349.0993 |
| 4 May 2022 | ZAC 299.4297 |
| 3 Nov 2021 | ZAC 289.5411 |
| 5 May 2021 | ZAC 287.9589 |
| 4 Nov 2020 | ZAC 304.9109 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Johannesburg Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.